SCPH250516C7500
- 0.05
- 0.000.00%
scPharmaceuticals Newsroom
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Sarepta Therapeutics (SRPT)
A Quick Look at Today's Ratings for ScPharmaceuticals(SCPH.US), With a Forecast Between $11 to $25
Maxim Group Maintains Buy on ScPharmaceuticals, Lowers Price Target to $12
Craig-Hallum Sticks to Its Buy Rating for ScPharmaceuticals (SCPH)
Maxim Adjusts Price Target on ScPharmaceuticals to $12 From $20, Keeps Buy Rating
ScPharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.
ScPharmaceuticals Analyst Ratings
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25
Strong Growth Prospects for ScPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: ScPharmaceuticals (SCPH), Intuitive Surgical (ISRG) and Labcorp Holdings (LH)
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for ScPharmaceuticals
H.C. Wainwright Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $18
H.C. Wainwright Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $18
ScPharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.
ScPharmaceuticals Analyst Ratings
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25